Skip to content

Monitoring of Hydration Status in Chronic Hemodialysis Patients

Measurement of Skinfold Thickness in Subscapular Area to Monitor Hydration Status in Chronic Hemodialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06798272
Enrollment
50
Registered
2025-01-29
Start date
2021-10-10
Completion date
2024-03-15
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis, Kidney Failure, Overhydration

Keywords

hemodialysis, water-electrolyte balance, dry body mass, skinfold thickness

Brief summary

Background Maintaining fluid balance is one of major challenges of the dialysis therapy. It includes, in particular, the management of dry body mass. We postulated that simple measurement of subscapular skinfold thickness before and after hemodialysis could help monitor hydration status in chronic dialysis patients. Aim of the study The aim of the study was to compare the conventional methods of monitoring hydration status during hemodialysis with an assessment of skin fold thickness. Materials and Methods 50 participants (21 F, 29 M; age 60 ±15 years) were enrolled. Directly before the hemodialysis session the following parameters were measured: body composition with bioimpedance spectroscopy, skinfold thickness in subscapular area with standardized caliper and blood tests: blood count, urea, n-terminal pro B-type natriuretic peptide (nt-proBNP) and pro-adrenomedullin (pro-ADM). The procedures were repeated at the end of three consecutive hemodialysis sessions.

Interventions

there were assessed three consecutive hemodialysis sessions

Sponsors

Medical University of Lodz
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic hemodialysis for at least 3 months

Exclusion criteria

* severe mental disabilities, poor compliance, any acute infection, instability of the cardiovascular hemodynamic condition

Design outcomes

Primary

MeasureTime frame
changes in overhydrationFrom enrollment to one week

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026